Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Ravaioli

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|June 9, 2025
Biopsy-free endpoints in MASH trials: A comparative look at MASHResInd and FASTFederico Ravaioli
The Journal of Nutrition|January 29, 2025
Generative Artificial Intelligence in Nutrition: A Revolution in Accessibility and PersonalizationNicola Pugliese, Federico Ravaioli
Digestive Diseases and Sciences|July 18, 2019
Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal SurveillanceFederico Ravaioli, Antonio Colecchia
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
Gaining knowledge for the choice and use of systemic therapies in the treatment of hepatocellular carcinoma also requires real life and investigators conducted observational studiesFabio Piscaglia, Federico Ravaioli
World Journal of Hepatology|January 28, 2025
Small bites, big impact: The importance of evening snacks in patients with advanced chronic liver diseaseFederica Perazza, Federico Ravaioli
Hepatology (Baltimore, Md.)|December 17, 2025
Reply: Beyond semantics-Acknowledging diagnostic differences between NAFLD and MASLDMadalina-Gabriela Indre, Federico Ravaioli
Alimentary Pharmacology & Therapeutics|May 11, 2019
Editorial: collagen proportionate area as a prognostic indicator in NAFLDFederico Ravaioli, Quentin M Anstee
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 15, 2023
A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinomaFabio Piscaglia, Vincenzo La Mura, Federico Ravaioli
Hepatobiliary Surgery and Nutrition|August 25, 2020
Clinical outcomes after treatment with direct-acting antivirals: not all concern hepatocellular carcinoma riskElton Dajti, Federico Ravaioli, Davide Festi, et al.
Hepatology (Baltimore, Md.)|February 13, 2024
Reply: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver diseaseRosa Lombardi, Andrea Dalbeni, Alessandro Mantovani, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|June 9, 2025
Biopsy-free endpoints in MASH trials: A comparative look at MASHResInd and FASTFederico Ravaioli
The Journal of Nutrition|January 29, 2025
Generative Artificial Intelligence in Nutrition: A Revolution in Accessibility and PersonalizationNicola Pugliese, Federico Ravaioli
Digestive Diseases and Sciences|July 18, 2019
Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal SurveillanceFederico Ravaioli, Antonio Colecchia
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
Gaining knowledge for the choice and use of systemic therapies in the treatment of hepatocellular carcinoma also requires real life and investigators conducted observational studiesFabio Piscaglia, Federico Ravaioli
World Journal of Hepatology|January 28, 2025
Small bites, big impact: The importance of evening snacks in patients with advanced chronic liver diseaseFederica Perazza, Federico Ravaioli
Hepatology (Baltimore, Md.)|December 17, 2025
Reply: Beyond semantics-Acknowledging diagnostic differences between NAFLD and MASLDMadalina-Gabriela Indre, Federico Ravaioli
Alimentary Pharmacology & Therapeutics|May 11, 2019
Editorial: collagen proportionate area as a prognostic indicator in NAFLDFederico Ravaioli, Quentin M Anstee
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 15, 2023
A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinomaFabio Piscaglia, Vincenzo La Mura, Federico Ravaioli
Hepatobiliary Surgery and Nutrition|August 25, 2020
Clinical outcomes after treatment with direct-acting antivirals: not all concern hepatocellular carcinoma riskElton Dajti, Federico Ravaioli, Davide Festi, et al.
Hepatology (Baltimore, Md.)|February 13, 2024
Reply: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver diseaseRosa Lombardi, Andrea Dalbeni, Alessandro Mantovani, et al.
Pageof 10